Bio-Connect
The figure shows a typical standard curve for the human C-terminal FGF23  ELISA. The immunoassay is calibrated against recombinant C-terminal FGF23 peptide.
The figure shows a typical standard curve for the human C-terminal FGF23  ELISA. The immunoassay is calibrated against recombinant C-terminal FGF23 peptide.
The figure shows a typical standard curve for the human C-terminal FGF23  ELISA. The immunoassay is calibrated against recombinant C-terminal FGF23 peptide.

FGF23 (C-terminal) ELISA

Research Use Only
BI-20702
Biomedica
Assay Sample TypeSerum, EDTA plasma, citrate plasma, heparin plasma
Product group Assays
€ 689,00
96 tests
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Biomedica
  • Product Name
    FGF23 (C-terminal) ELISA
  • Delivery Days Customer
    7
  • Assay Detection Range
    0 – 20 pmol/l (= 150.4 pg/ml)
  • Assay Precision
    In-between (n=10): ≤ 10 % CV. Within-run (n=6): ≤ 12 % CV
  • Assay Sample Type
    Serum, EDTA plasma, citrate plasma, heparin plasma
  • Assay Sensitivity
    0.08 pmol/l (= 0.6 pg/ml)
  • Assay Specificity
    Human FGF23 (Intact and C-terminal fragments of endogenous and recombinant human FGF23)
  • Assay Test Principle
    The C-terminal FGF 23 ELISA kit is a sandwich enzyme immunoassay for the quantitative determination of FGF23 in human serum and plasma samples.
  • Assay Time
    20-24 h / 1 h / 30 min
  • Certification
    Research Use Only
  • Scientific Description
    The Human FGF23 (C-terminal) ELISA kit is an overnight, 96-well sandwich ELISA for the quantitative determination of FGF23 in human serum and plasma. The assay employs human serum-based standards to ensure the measurement of biologically reliable data. The FGF-23 ELISA kit uses antibodies with characterized binding affinities.
  • UNSPSC
    41116133

References

  • Povaliaeva A, Zhukov A, Tomilova A, et al. Dynamic evaluation of vitamin d metabolism in post-bariatric patients. J Clin Med. 2023;13(1):7.
    Read more